HomeCompareTCDA vs DIVO

TCDA vs DIVO: Dividend Comparison 2026

TCDA yields 1851.85% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TCDA wins by $4863045258.28M in total portfolio value
10 years
TCDA
TCDA
● Live price
1851.85%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4863045258.31M
Annual income
$4,396,067,798,536,862.00
Full TCDA calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — TCDA vs DIVO

📍 TCDA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTCDADIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TCDA + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TCDA pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCDA
Annual income on $10K today (after 15% tax)
$157,407.41/yr
After 10yr DRIP, annual income (after tax)
$3,736,657,628,756,332.50/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, TCDA beats the other by $3,736,657,628,755,475.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCDA + DIVO for your $10,000?

TCDA: 50%DIVO: 50%
100% DIVO50/50100% TCDA
Portfolio after 10yr
$2431522629.17M
Annual income
$2,198,033,899,268,935.20/yr
Blended yield
90.40%
📊

Analyst Conviction Gap

Where Wall Street is split right now

TCDA
Analyst Ratings
1
Buy
2
Hold
1
Sell
Consensus: Hold
Price Target
$16.00
+14714.8% upside vs current
Range: $16.00 — $16.00
Altman Z
-16.7
Piotroski
1/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCDA buys
0
DIVO buys
0
No recent congressional trades found for TCDA or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTCDADIVO
Forward yield1851.85%6.62%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4863045258.31M$31.0K
Annual income after 10y$4,396,067,798,536,862.00$1,008.47
Total dividends collected$4829695825.56M$8.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: TCDA vs DIVO ($10,000, DRIP)

YearTCDA PortfolioTCDA Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$195,885$185,185.19$11,362$661.96+$184.5KTCDA
2$3,599,787$3,390,190.12$12,860$702.91+$3.59MTCDA
3$62,077,580$58,225,807.67$14,504$743.56+$62.06MTCDA
4$1,004,826,655$938,403,644.40$16,303$783.73+$1004.81MTCDA
5$15,271,043,115$14,195,878,594.10$18,268$823.31+$15271.02MTCDA
6$217,970,436,268$201,630,420,135.20$20,408$862.17+$217970.42MTCDA
7$2,922,911,796,978$2,689,683,430,171.31$22,737$900.20+$2922911.77MTCDA
8$36,835,711,310,169$33,708,195,687,401.73$25,266$937.31+$36835711.28MTCDA
9$436,427,532,502,759$397,013,321,400,878.75$28,008$973.42+$436427532.47MTCDA
10$4,863,045,258,314,815$4,396,067,798,536,862.00$30,977$1,008.47+$4863045258.28MTCDA

TCDA vs DIVO: Complete Analysis 2026

TCDAStock

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Full TCDA Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this TCDA vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCDA vs SCHDTCDA vs JEPITCDA vs OTCDA vs KOTCDA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.